UK markets closed
  • NIKKEI 225

    27,728.12
    +144.04 (+0.52%)
     
  • HANG SENG

    26,204.69
    -221.86 (-0.84%)
     
  • CRUDE OIL

    69.02
    +0.87 (+1.28%)
     
  • GOLD FUTURES

    1,806.30
    -8.20 (-0.45%)
     
  • DOW

    34,976.88
    +184.21 (+0.53%)
     
  • BTC-GBP

    29,349.81
    +760.22 (+2.66%)
     
  • CMC Crypto 200

    1,006.37
    +30.48 (+3.12%)
     
  • ^IXIC

    14,881.87
    +101.34 (+0.69%)
     
  • ^FTAS

    4,089.91
    +4.44 (+0.11%)
     

Clinical Laboratory Tests Market Worth US$421.06 billion by 2031: Visiongain Research Inc.

·6-min read

Visiongain has published a new report on “Clinical Laboratory Tests Market Report Forecast 2021-2031”. Forecasts by Type (Basic Metabolic Panel Tests, Complete Blood Count, HGB/HCT Tests, Electrolytes Testing, BUN Creatinine Tests, Liver Panel Tests, HbA1c Tests, Comprehensive Metabolic Panel Tests, Lipid Panel Tests, Renal Panel Tests,), End-Use (Central Laboratories, Primary Clinics), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), PLUS COVID-19 Recovery Scenarios

Visiongain’s industry analyst says: ‘The worldwide demand for clinical laboratory tests is expected to rise at a lucrative US$421.06 billion by 2031 from its previous value of US$206.79 billion in 2021’.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/clinical-laboratory-tests-market-2021/#download_sampe_div

Clinical Laboratory Tests to Support Population Health with Data Analytics and Extended Care Services.

It is expected that clinical laboratory tests can offer and encourage population health by providing services (e.g., home-based health risk assessments and related services) to identify care gaps in a population, provide clinical solutions to close gaps, and facilitate customer interaction with a solution. These types of programs enable healthcare professionals, insurance plans, sponsors and provide their patient populations with quality coverage by finding and covering gaps in care for their patient populations and by helping them to provide the right populations and individuals with the most efficient healthcare. Some of the main offerings by businesses harness the power of assets and skills (e.g., contact centers, customer support centers, and mobile staff, including professionals) and incorporate robust health data, including data analytics and extended care services. For example, a ground-breaking new service by QUEST Diagnostics in 2019 i.e., Quest Lab StewardshipTM employs machine learning to help maximize the use of laboratory tests. The technological advancements by major players are anticipated to offer innovative clinical laboratory test products over the forecast period.

How the Clinical Laboratory Tests Market report helps you
In summary, our 310+ page report provides you with the following knowledge:


• Revenue forecasts to 2031 for Clinical Laboratory Tests Market, with forecasts for Type and End-Use, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 17 key national markets– See forecasts for the Clinical Laboratory Tests market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the Clinical Laboratory Tests market. Some of the company’s profiled in this report include Abbott, ARUP Laboratories, OPKO Health, Inc., Charles River, Neogenomics Laboratories, Inc., Genoptix, Inc., Laboratory Corporation of America Holdings (LabCorp), QIAGEN, Quest Diagnostics, Siemens Healthcare Private Limited, Sonic Healthcare, Fresenius Medical Care Holdings, Inc., Merck KgaA, Tulip Diagnostics, and BiosinoBio-technology and Science Inc.

Stringent Regulatory Policies across Economies to Impede Market Growth
The maintenance of quality of clinical laboratory products is governed by country specific regulatory bodies. These bodies ensure protection from risks caused by flaws in design, technology, packaging, and manufacturing of the equipment or peripherals. In India, The National Medical Device Policy 2015 has been devised to strengthen the domestic manufacturing of medical devices in India and minimizing dependency on importing equipment’s. The Schedule M-IV and M-III of D and C Act 1940 and Rules 1945 have been framed, which describe quality management and GMP required for manufacturing in clinical laboratory products.

Get Detailed TOC @https://www.visiongain.com/report/clinical-laboratory-tests-market-2021/#download_sampe_div

Rising Demand for Early Disease Diagnosis to Boost Clinical Laboratory Tests Market
The global clinical laboratory test industry is projected to grow on account of three major advances i.e., macro-health patterns spreading through the market, and support from both patients and policymakers to enhance disease prevention. As it stands, approximately 75% of professional decisions are focused on medical diagnostic evaluations that help to detect or validate the existence of a disease. There are hundreds of studies, ranging from radiology (techniques used for clinical diagnosis and therapy purposes to produce visual images of the body) and in vitro (outside the body, e.g., blood, biopsies) to in vivo tests (inside the body).

Leading players profiled in this report include:

Some of the companies profiled in the report include Abbott, OPKO Health, Inc., ARUP Laboratories, Genoptix, Inc., Charles River, Neogenomics Laboratories, Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, QIAGEN, Siemens Healthcare Private Limited, Sonic Healthcare, Fresenius Medical Care Holdings, Inc., Merck KgaA, Tulip Diagnostics, and BiosinoBio-technology and Science Inc.

Information found nowhere else
with our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the respiratory inhalers market and leading companies. You will find data, trends and predictions.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Find more research reports on the Pharma Contract Industry, please click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.

Contact:
Sara Peerun
Commercial Director
Visiongain Inc.
Tel: + 44 207 549 9987
USA Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
Email: sara.peerun@visiongain.com
Web: https://www.visiongain.com/
Follow Us: LinkedIn | Twitter
-
SOURCE Visiongain Limited.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting